SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Cell Genesys (CEGE)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: david james who wrote (868)4/9/2000 2:33:00 AM
From: Gemini  Read Replies (1) of 1298
 
Hi David,

It's good to be running into you again since our Eco days.

Last week I initially bought CEGE after reading an article in an old NAIC periodical whereby the writer recommended the stock (this could be old news in this thread?) when it was around 50 and predicted it would shoot up to 75 based upon the fact it owned approximately 25% of ABGX at the time.

So that purchasing it in the low 20's looked like a real bargain particularly in light of its cash position ("CASH IS KING"), R&D technologies, ongoing clinical trials and patents.

With so much cash and adequate revenues, could we see CEGE become another CMGI whereby it would buy up promising private biotech companies, make them profitable, initiate IPO's, while retaining a majority piece of the action?

It sounds like a sensible plan to me.

All the best, Allan
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News